Agenus Inc. (AGEN) vs Orchestra BioMed Holdings, Inc. (OBIO)
A side-by-side comparison of Agenus Inc. and Orchestra BioMed Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AGEN
Agenus Inc.
$7.78HealthcareDelayed quote: Oct 6, 2026, 1:30 PM EDT
OBIO
Orchestra BioMed Holdings, Inc.
$5.90HealthcareDelayed quote: Oct 6, 2026, 1:29 PM EDT
Total return — AGEN vs OBIO
growth of $100 · dividends reinvested · last 6yAGEN -85.4% (-27.4%/yr)OBIO -47.1% (-10.1%/yr)OBIO compounded faster over this window
AGEN OBIO
AGEN vs OBIO: by the numbers
- •OBIO is the larger company ($353M vs $324M market cap).
- •AGEN is profitable (69.34% net margin) while OBIO runs a net loss (-184.60%).
- •OBIO grew revenue faster over the past five years (148.45% vs 14.13% CAGR).
Metrics side by side
Valuation
| Metric | AGEN | OBIO |
|---|---|---|
| P/E ratio | 2.94 | N/A |
| Forward P/E | 29.07 | N/A |
| P/S ratio | 2.44 | 11.04 |
| P/B ratio | N/A | 18.27 |
| EV / EBITDA | 8.45 | N/A |
Profitability
| Metric | AGEN | OBIO |
|---|---|---|
| Gross margin | 29.63% | 99.32% |
| Operating margin | -18.00% | -154.73% |
| Net margin | 69.34% | -184.60% |
| ROE | N/A | -200.64% |
| ROIC | N/A | -56.73% |
Growth (annualized)
| Metric | AGEN | OBIO |
|---|---|---|
| Revenue CAGR (5Y) | 14.13% | 148.45% |
| Total return CAGR (5Y) | -40.10% | -9.35% |
Frequently asked
- Which has grown faster, AGEN or OBIO?
- Over the past five years, OBIO grew revenue faster — AGEN at a 14.13% CAGR versus OBIO at 148.45%.
- Is AGEN or OBIO more profitable?
- AGEN runs the higher net margin — AGEN at 69.34% versus OBIO at -184.60%.
- How have AGEN and OBIO total returns compared?
- Over the past 5 years, AGEN delivered -40.10% and OBIO delivered -9.35% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Agenus P/E ratioAgenus ROEOrchestra BioMed ROEAgenus operating marginOrchestra BioMed operating marginAgenus revenue growthOrchestra BioMed revenue growthAgenus free cash flowOrchestra BioMed free cash flow
Agenus & Orchestra BioMed appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.